• Urinary Tract Infection (UTI) Pathogen Panel with Antibiotic Resistance, Molecular
  • Candida albicans, Antigen
  • Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
  • Microalbumin, Urine
  • Solute Carrier Organic Anion Transporter Family, Member 1B1 (SLCO1B1) Genotyping, Statin Sensitivity
  • Arylsulfatase A (ARSA) Mutation Analysis, Molecular Methods
  • Benign neoplasm, pituitary gland (pituitary adenoma)
  • Clonazepam, Urine
  • Prader-Willi syndrome
  • Dyskeratosis Congenita
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Peritoneal Fluid
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Peritoneal Fluid
Medical Test

Clinical Utility
Access to Cancer Antigen (CA) 19-9, Peritoneal Fluid is restricted.
Loading...